Elevated risks for cancer patients have been reported, but is there any data on specific types or categories? Are NETs specifically at more or less risk?


We do not know the answer to this question. In February, a group from China published their experience in patients with COVID-19 and cancer (Liang et al. Lancet, (21) 3: 335-337, 2020). In this paper, they describe an increased risk of COVID-19 in cancer patients, which is higher than that observed in non-cancer patients in China. However, the number of cancer patients included was small (18 patients), very heterogeneous, and the full details of their cancer history are not known. Therefore, it is difficult to extrapolate from this study. For example, we do not know the cancer stage, types of cancer therapy, or white blood count levels.

Posted 4 months agoby globeseek